Biosynex SA (ENXTPA: ALBIO)
Health Care · Health Care Equipment & Supplies · FR
€0.83
-2.35% today · +26.1% 1Y
Biosynex SA (ENXTPA: ALBIO) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $17.54M and employs 397 people.
Over the last twelve months the share price has gained 26.1%, trading between 0.46 and 1.57.
Tweenvest scores Biosynex SA across four factors: quality 55/100, value 57/100, growth 0/100. Its strongest factor is value.
ALBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.54M
- Revenue (TTM)
- $111.77M
- P/E
- —
- EPS
- -3.16
- Dividend yield
- —
- Beta (5Y)
- 0.78
- 52-week high
- €1.57
- 52-week low
- €0.46
- Avg volume (3M)
- —
- Shares outstanding
- 18.43M
- Employees
- 397
- Next earnings
- —
About Biosynex SA
Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.
- ISIN
- FR0011005933
- Founded
- 2005
- Listed since
- Mar 28, 2011
- Exchange
- Euronext Paris
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| European Medical SolutionsENXTBR: ALEMS | $18.48M | €3.90 | -7.14% |
| Elbit Real Estate Ltd.TASE: ELRL | $18.38M | ₪4.22 | +2.75% |
| Lifeward Ltd.NasdaqCM: LFWD | $18.38M | $6.23 | -4.01% |
| Vitasora Health LimitedASX: VHL | $17.97M | AU$0.01 | -15.38% |
| Lifecare ASAOB: LIFE | $17.43M | Nkr0.42 | +2.57% |
| Guided Therapeutics, Inc.OTCPK: GTHP | $17.38M | $0.18 | -18.18% |
| Sejong Medical Co., Ltd.KOSDAQ: A258830 | $16.97M | ₩— | — |
| Femasys Inc.NasdaqCM: FEMY | $16.75M | $1.83 | -8.75% |
Figures last refreshed Oct 11, 2026.